INCB-160058

N/A

Report date: 2025/05/15 11:45:13
NMEFirst In Class

Base Information

Drug NameINCB-160058
Drug Alias NameINCB160058INCB-160058INCB-100658
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJAK2 V617F inhibitors
TargetsJAK2 V617F
Therapy Area/IndicationsMyeloproliferative Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNorway +[9
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesIncyte Corp
Inactive CompaniesN/A
Active IndicationsMyeloproliferative Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A